BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25630814)

  • 1. Molecular adjuvants based on nonpyrogenic lipophilic derivatives of norAbuMDP/GMDP formulated in nanoliposomes: stimulation of innate and adaptive immunity.
    Knotigová PT; Zyka D; Mašek J; Kovalová A; Křupka M; Bartheldyová E; Kulich P; Koudelka Š; Lukáč R; Kauerová Z; Vacek A; Horynová MS; Kozubík A; Miller AD; Fekete L; Kratochvílová I; Ježek J; Ledvina M; Raška M; Turánek J
    Pharm Res; 2015 Apr; 32(4):1186-99. PubMed ID: 25630814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of immune response towards non-lipidized Borrelia burgdorferi recombinant OspC antigen by binding onto the surface of metallochelating nanoliposomes with entrapped lipophilic derivatives of norAbuMDP.
    Křupka M; Mašek J; Bartheldyová E; Turánek Knötigová P; Plocková J; Korvasová Z; Škrabalová M; Koudelka Š; Kulich P; Zachová K; Czerneková L; Strouhal O; Horynová M; Šebela M; Miller AD; Ledvina M; Raška M; Turánek J
    J Control Release; 2012 Jun; 160(2):374-81. PubMed ID: 22387453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallochelating liposomes with associated lipophilised norAbuMDP as biocompatible platform for construction of vaccines with recombinant His-tagged antigens: preparation, structural study and immune response towards rHsp90.
    Mašek J; Bartheldyová E; Turánek-Knotigová P; Skrabalová M; Korvasová Z; Plocková J; Koudelka S; Skodová P; Kulich P; Křupka M; Zachová K; Czerneková L; Horynová M; Kratochvílová I; Miller AD; Zýka D; Michálek J; Vrbková J; Sebela M; Ledvina M; Raška M; Turánek J
    J Control Release; 2011 Apr; 151(2):193-201. PubMed ID: 21256901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpyrogenic Molecular Adjuvants Based on norAbu-Muramyldipeptide and norAbu-Glucosaminyl Muramyldipeptide: Synthesis, Molecular Mechanisms of Action, and Biological Activities in Vitro and in Vivo.
    Effenberg R; Turánek Knötigová P; Zyka D; Čelechovská H; Mašek J; Bartheldyová E; Hubatka F; Koudelka Š; Lukáč R; Kovalová A; Šaman D; Křupka M; Barkocziova L; Kosztyu P; Šebela M; Drož L; Hučko M; Kanásová M; Miller AD; Raška M; Ledvina M; Turánek J
    J Med Chem; 2017 Sep; 60(18):7745-7763. PubMed ID: 28829599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of haemopoiesis and protection of mice against radiation injury by synthetic analogues of muramyldipeptide incorporated in liposomes.
    Turánek J; Záluská D; Hofer M; Vacek A; Ledvina M; Jezek J
    Int J Immunopharmacol; 1997; 19(9-10):611-7. PubMed ID: 9637362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal preparations of muramyl glycopeptides as immunomodulators and adjuvants.
    Turánek J; Ledvina M; Kasná A; Vacek A; Hríbalova V; Krejcí J; Miller AD
    Vaccine; 2006 Apr; 24 Suppl 2():S2-90-1. PubMed ID: 16823942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stimulation of the nonspecific resistance by beta-heptylglycoside-muramyldipeptide in mice].
    Kaliuzhin OV; Kaliuzhin VV; Zemliakov AE; Elkina SI; Shkalev MV; Sergeev VV
    Biull Eksp Biol Med; 1999 May; 127(5):543-5. PubMed ID: 10399577
    [No Abstract]   [Full Text] [Related]  

  • 8. [Muramyl dipeptide derivatives in experimental and clinical use].
    Kaliuzhin OV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):104-8. PubMed ID: 9532704
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of liposomal glucosaminyl-muramyl dipeptide on superoxide and nitric oxide production by murine macrophages].
    Parshykov OV; Stefanov OV
    Ukr Biokhim Zh (1999); 2009; 81(5):74-82. PubMed ID: 20387650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives.
    Jain V; Vyas SP; Kohli DV
    Nanomedicine; 2009 Sep; 5(3):334-44. PubMed ID: 19523433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunostimulating activity of muramyl dipeptide and its derivatives].
    Karsonova MI; Andronova TM; Pinegin BV; Khaitov RM
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):104-10. PubMed ID: 10852007
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
    Hornung RL; Longo DL; Gowda VL; Kwak LW
    Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of nonspecific immunity, haemopoiesis and protection of mice against radiation injury by 1-adamantylamide-L-alanyl-D-isoglutamine incorporated in liposomes.
    Turánek J; Záluská D; Vacek A; Borkovcová P; Thurnvaldová J; Bláha L; Masek K
    Int Immunopharmacol; 2001 Jan; 1(1):167-75. PubMed ID: 11367514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimetastatic effect of a liposome-enclosed analog of muramyl dipeptide].
    Umanskiĭ VIu; Stefanov AV; Bondar' OP; Balitskiĭ KP; Pinchuk VG
    Vopr Onkol; 1988; 34(4):433-8. PubMed ID: 2837005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic and toxicologic study of disaccharide tripeptide glycerol dipalmitoyl: a new lipophilic immunomodulator.
    Vosika GJ; Cornelius DA; Bennek JA; Sadlik JR; Gilbert CW
    Mol Biother; 1990 Mar; 2(1):50-6. PubMed ID: 2185794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An increase in the immunogenicity of bacterial antigens under the influence of one of the derivatives of muramyl dipeptide].
    Britsina MV; Shepeleva IB; Baturo AP; Elkina SI; Kalina NG; Andronova TM; Ermolova EV; Zakharova NS; Ivanov VT; Sokolova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (5-6):43-5. PubMed ID: 1455969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of muramyl dipeptide analog, GMPD, incorporated into liposomes of various composition on the functional activity of macrophages].
    Stefanov AV; Bondar' OP; Umanskiĭ VIu; Lishko VK; Baletskiĭ KP
    Ukr Biokhim Zh (1978); 1989; 61(6):63-9. PubMed ID: 2561033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of anomeric pairs of lipophilic glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Kalyuzhin OV; Zemlyakov AE; Kalina NG; Mulik EL; Kuzovlev FN; Makarova OV
    Bull Exp Biol Med; 2008 May; 145(5):623-5. PubMed ID: 19145298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Oxy lipid-based click chemistry for orthogonal coupling of mannan onto nanoliposomes prepared by microfluidic mixing: Synthesis of lipids, characterisation of mannan-coated nanoliposomes and in vitro stimulation of dendritic cells.
    Bartheldyová E; Turánek Knotigová P; Zachová K; Mašek J; Kulich P; Effenberg R; Zyka D; Hubatka F; Kotouček J; Čelechovská H; Héžová R; Tomečková A; Mašková E; Fojtíková M; Macaulay S; Bystrický P; Paulovičová L; Paulovičová E; Drož L; Ledvina M; Raška M; Turánek J
    Carbohydr Polym; 2019 Mar; 207():521-532. PubMed ID: 30600036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muramylpeptides augment expression of Ia-antigens on mouse macrophages.
    Nesmeyanov VA; Khaidukov SV; Komaleva RL; Andronova TM; Ivanov VT
    Biomed Sci; 1990 Feb; 1(2):151-4. PubMed ID: 2102779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.